KIM GILMORE: Open Payments
NPI 1184810665 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 10 payments from 6 companies in 2025. Trend: 2023 $940 · 2024 $218 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $297 |
| Neurocrine BioSciences, Inc. | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Vanda Pharmaceuticals Inc. | 1 | $101 |
| Axsome Therapeutics, Inc. | 1 | $101 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: CAPLYTA, INGREZZA, UZEDY, FANAPT, Auvelity, REXULTI.
Industry payments across SC — which companies pay providers there.
